Trends in research on acute lung injury/acute respiratory distress syndrome associated with viral pneumonia from 1992 to 2022: a 31-year bibliometric analysis

Purpose Acute lung injury/acute respiratory distress syndrome (ALI/ARDS) is a dangerous symptom in patients with severe viral pneumonia. This study aims to comprehensively review the cooperation and influence of countries, institutions, authors and co-cited journals/authors/references and keywords in the field of ALI/ARDS associated with viral pneumonia from the perspective of bibliometrics, evaluate the clustering evolution of knowledge structure, and find hot trends and emerging topics. Methods Publications on ALI/ARDS associated with viral pneumonia published from January 1, 1992 to December 31, 2022 were extracted from the Web of Science core collection. The document type was limited to original article or review, with the language set to English. Citespace was used to conduct the bibliometric analysis. Results A total of 929 articles were included, and the number of them generally increased over time. The countries with the most published articles in this field are the United States (320 papers) and Fudan University is the institution (15 papers) with the most research results. The New England Journal of Medicine was the most frequently co-cited journal, while the most influential co-cited journal was American Journal of Clinical Pathology. Reinout A Bem and Cao Bin were the most prolific author, but there was no leader in this field. The keywords with both high frequency and high centrality were “pneumonia” (Freq = 169, Central = 0.15), “infection” (Freq = 133, Central = 0.15), “acute lung injury” (Freq = 112, Central = 0.18), “respiratory distress syndrome” (Freq = 108, Central = 0.24), and “disease” (Freq = 61, Central = 0.17). “Failure” was the first keyword with citation bursts. Meanwhile, “coronavirus,” “cytokine storm” and “respiratory syndrome coronavirus” continue to burst. Conclusion Although there was a surge in literature since 2020, attentions to ALI/ARDS associated with viral pneumonia were still insufficient over last three decades. The communication and cooperation among countries, institutions and authors need to be further strengthened.

[1]  Huiyang Zhou,et al.  Severe fever with thrombocytopenia syndrome virus trends and hotspots in clinical research: A bibliometric analysis of global research , 2023, Frontiers in Public Health.

[2]  Z. Zhao,et al.  Trends in metabolic signaling pathways of tumor drug resistance: A scientometric analysis , 2022, Frontiers in Oncology.

[3]  Jingjing Shi,et al.  A bibliometric analysis of T cell and atherosclerosis , 2022, Frontiers in Immunology.

[4]  Jiabao Guo,et al.  Research trends and hotspots of exercise for Alzheimer’s disease: A bibliometric analysis , 2022, Frontiers in Aging Neuroscience.

[5]  Lixin Xie,et al.  Advances in the use of exosomes for the treatment of ALI/ARDS , 2022, Frontiers in Immunology.

[6]  S. Lyons,et al.  PTP1B inhibitors protect against acute lung injury and regulate CXCR4 signaling in neutrophils , 2022, JCI insight.

[7]  Mehmet Nurullah Kurutkan,et al.  Bibliometric analysis of acute respiratory distress syndrome (ARDS) studies published between 1980 and 2020. , 2022, Advances in clinical and experimental medicine : official organ Wroclaw Medical University.

[8]  Xiaojuan Hong,et al.  Molecular Mechanisms of Exercise on Cancer: A Bibliometrics Study and Visualization Analysis via CiteSpace , 2022, Frontiers in Molecular Biosciences.

[9]  Yang Song,et al.  Study on Pain Catastrophizing From 2010 to 2020: A Bibliometric Analysis via CiteSpace , 2021, Frontiers in Psychology.

[10]  Zhongming Luo,et al.  First Systematic Review on Health Communication Using the CiteSpace Software in China: Exploring Its Research Hotspots and Frontiers , 2021, International journal of environmental research and public health.

[11]  V. Conti,et al.  Characteristics of viral pneumonia in the COVID-19 era: an update , 2021, Infection.

[12]  Yongsheng Fan,et al.  Visualization and bibliometric analysis of cAMP signaling system research trends and hotspots in cancer , 2021, Journal of Cancer.

[13]  Linli Zheng,et al.  Epilepsy Occurrence and Circadian Rhythm: A Bibliometrics Study and Visualization Analysis via CiteSpace , 2020, Frontiers in Neurology.

[14]  Adeleh Sahebnasagh,et al.  Neutrophil elastase inhibitor (sivelestat) may be a promising therapeutic option for management of acute lung injury/acute respiratory distress syndrome or disseminated intravascular coagulation in COVID‐19 , 2020, Journal of clinical pharmacy and therapeutics.

[15]  J. Barr,et al.  Acute Respiratory Distress Syndrome: Etiology, Pathogenesis, and Summary on Management , 2020, Journal of intensive care medicine.

[16]  A. Basu,et al.  Faculty Opinions recommendation of Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. , 2020, Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature.

[17]  Q. Ye,et al.  The pathogenesis and treatment of the `Cytokine Storm' in COVID-19 , 2020, Journal of Infection.

[18]  J. Xiang,et al.  Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study , 2020, The Lancet.

[19]  Ting Yu,et al.  Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study , 2020, The Lancet Respiratory Medicine.

[20]  E. Holmes,et al.  Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding , 2020, The Lancet.

[21]  S. Perlman,et al.  Another Decade, Another Coronavirus , 2020, The New England journal of medicine.

[22]  Z. Memish,et al.  MERS-CoV as an emerging respiratory illness: A review of prevention methods , 2019, Travel Medicine and Infectious Disease.

[23]  David K. Meyerholz,et al.  IFN-I response timing relative to virus replication determines MERS coronavirus infection outcomes. , 2019, The Journal of clinical investigation.

[24]  G. H. Ha,et al.  A Bibliometric Analysis of the Global Research Trend in Child Maltreatment , 2018, International journal of environmental research and public health.

[25]  J. Chiche,et al.  Use of early corticosteroid therapy on ICU admission in patients affected by severe pandemic (H1N1)v influenza A infection , 2010, Intensive Care Medicine.

[26]  R. Perez-Padilla,et al.  Pneumonia and respiratory failure from swine-origin influenza A (H1N1) in Mexico. , 2009, The New England journal of medicine.

[27]  Michael Bailey,et al.  Extracorporeal Membrane Oxygenation for 2009 Influenza A(H1N1) Acute Respiratory Distress Syndrome. , 2009, JAMA.

[28]  L. Figueiredo,et al.  Viral pneumonia: epidemiological, clinical, pathophysiological and therapeutic aspects. , 2009, Jornal brasileiro de pneumologia : publicacao oficial da Sociedade Brasileira de Pneumologia e Tisilogia.

[29]  Angus Nicoll,et al.  Avian influenza A (H5N1) infection in humans. , 2005, The New England journal of medicine.

[30]  S. Kaparthi,et al.  A Bibliometric Analysis , 2005 .

[31]  J. Peiris,et al.  Re-emergence of fatal human influenza A subtype H5N1 disease , 2004, The Lancet.

[32]  J. Peiris,et al.  Epidemiology and cause of severe acute respiratory syndrome (SARS) in Guangdong, People's Republic of China, in February, 2003 , 2003, The Lancet.

[33]  Wenfang Li,et al.  Mapping theme trends and recognizing hot spots in viral pneumonia: a bibliometric analysis of global research. , 2022, American journal of translational research.

[34]  Dennis Andersson,et al.  A retrospective cohort study , 2018 .

[35]  S. Bezerra,et al.  Lung pathology in fatal novel human influenza A (H1N1) infection. , 2010, American journal of respiratory and critical care medicine.

[36]  B. Ramesh Babu,et al.  a Scientometric Analysis , 2008 .

[37]  K. Johnson An Update. , 1984, Journal of food protection.

[38]  S. Osajima [VIRAL PNEUMONIA]. , 1963, Naika. Internal medicine.